Your browser doesn't support javascript.
loading
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Lee, Eudocia Q; Selig, Wendy; Meehan, Clair; Bacha, Jeffrey; Barone, Amy; Bloomquist, Erik; Chang, Susan M; de Groot, John F; Galanis, Evanthia; Hassan, Islam; Kalidas, Chitkala; Khasraw, Mustafa; Kvedar, Joseph C; Lassman, Andrew B; Puduvalli, Vinay; Sahebjam, Solmaz; Schwamm, Lee H; Tamir, Sharon; Welch, Mary; Yung, W K Alfred; Zadeh, Gelareh; Arons, David; Wen, Patrick Y.
Affiliation
  • Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Selig W; WSCollaborative, McLean, Virginia, USA.
  • Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Bacha J; Edison Oncology Holding Corp., Menlo Park, California, USA.
  • Barone A; Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA.
  • Bloomquist E; Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA.
  • Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • de Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Galanis E; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hassan I; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Kalidas C; Bayer Pharmaceuticals, Hillsborough, New Jersey, USA.
  • Khasraw M; Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Kvedar JC; Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
  • Puduvalli V; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sahebjam S; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
  • Schwamm LH; Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Tamir S; Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA.
  • Welch M; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
  • Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zadeh G; MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.
  • Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Neuro Oncol ; 23(8): 1252-1260, 2021 08 02.
Article de En | MEDLINE | ID: mdl-33822177

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / COVID-19 Type d'étude: Clinical_trials Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Neuro Oncol Sujet du journal: NEOPLASIAS / NEUROLOGIA Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / COVID-19 Type d'étude: Clinical_trials Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: Neuro Oncol Sujet du journal: NEOPLASIAS / NEUROLOGIA Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni